Relapsed or Refractory Chronic Lymphoproliferative Disorders
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Chronic Lymphoproliferative Disorders
| Record | Firm | Date |
|---|---|---|
| Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders (NCT01224769) | Gruppo Italiano Studio Linfomi | 2005-09-01 |
Track Relapsed or Refractory Chronic Lymphoproliferative Disorders automatically
Every clearance here is in the API, with alerts when new ones post.